📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-07 13:02
161 analysed today
FollowTelegram
161
Today
149,562
All-time analysed
42,894
Positive
6,654
Negative
91,341
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
16 announcements match the current filters (relevance ≥ 5).
Quick Heal SVP - Enterprise Sales Samuel Sathyajith Steps Down Effective Sep 4, 2026
Quick Heal Technologies Limited has confirmed the cessation of Mr. Samuel Sathyajith as Senior Vice President - Enterprise Sales, effective September 4, 2026, following his resignation letter dated August 11, 2026. The departure comes at a crucial juncture as Quick Heal pivots toward its enterprise arm (Seqrite), which contributes approximately 44% of gross revenue. The company reported TTM revenue of Rs 249 Cr and a TTM net loss of Rs 11 Cr, making enterprise sales execution critical to returning to operating profitability.
Confidence: HIGH
What changedMr. Samuel Sathyajith's tenure as Senior Vice President - Enterprise Sales concluded on September 4, 2026.
Why it mattersThe Enterprise business is Quick Heal's primary growth driver amid consumer segment stagnation; leadership disruption in sales could impact deal pipelines and enterprise revenue growth.
Effective Date of Cessation: September 4, 2026Resignation Intimation Date: August 11, 2026Enterprise Share of Gross Revenue: 44%TTM Net Profit: Rs -11 Cr
📅 Short termSales transition risks could lead to temporary friction in enterprise and government contract conversions over the coming quarters.
📈 Long termSustainable turnaround depends heavily on Seqrite's EDR and XDR product expansion; smooth succession in enterprise sales leadership will be vital.
⚠ Risk flags
- Key management departure in the high-growth Enterprise business segment
- Ongoing operational losses (TTM PAT of Rs -11 Cr)
Key Highlights
Cessation of Mr. Samuel Sathyajith as Senior Vice President - Enterprise Sales effective September 4, 2026
Formal resignation was submitted on August 11, 2026, citing pursuit of the next phase of his career
Enterprise division (Seqrite) accounts for ~44% of company gross revenue
Company posted an operating loss of Rs 17.57 Cr in Q1 FY27 (Jun 2026)
👀 What to Watch
Track announcements regarding the appointment of new enterprise sales leadership and monitor enterprise revenue momentum in the upcoming Q2 FY27 results.
Quick Heal SVP of Enterprise Sales Samuel Sathyajith Resigns; Exit by Sep 4, 2026
Quick Heal Technologies announced that Mr. Samuel Sathyajith, Senior Vice President - Enterprise Sales, has tendered his resignation on August 11, 2026, to pursue other professional opportunities. His last working day will be on or before September 4, 2026. This departure comes at a crucial juncture as Quick Heal pivots toward its Enterprise segment (Seqrite), which contributes approximately 44% of gross revenue. The company will announce the effective cessation date within regulatory timelines.
Confidence: HIGH
What changedMr. Samuel Sathyajith, Senior Vice President - Enterprise Sales, resigned on August 11, 2026, with an effective exit date on or before September 4, 2026.
Why it mattersThe Enterprise division (Seqrite) is Quick Heal's primary growth driver contributing ~44% of gross revenue, making leadership continuity critical during its transition away from a stagnant consumer segment.
Resignation Intimation Date: August 11, 2026Last Working Day: On or before September 4, 2026Enterprise share of gross revenue: ~44%
📅 Short termLow operational disruption expected over the immediate weeks ahead of his transition date of September 4, 2026.
📈 Long termLeadership execution risk in scaling the mid-market and SMB enterprise sales pipeline if key leadership replacement is delayed.
⚠ Risk flags
- Key personnel transition risk in the core growth division (Enterprise/Seqrite)
Key Highlights
Mr. Samuel Sathyajith resigned as Senior Vice President - Enterprise Sales on August 11, 2026
Effective cessation date is scheduled on or before September 4, 2026
Enterprise business (Seqrite) accounts for ~44% of gross revenue under the ongoing strategic pivot
Departure stated as voluntary to pursue the next phase of his professional journey
👀 What to Watch
Track announcements regarding succession planning and appointment of the new Enterprise Sales head, alongside upcoming quarterly Enterprise (Seqrite) segment growth figures.
Quick Heal Appoints 30-Year IBM Veteran Rajiv Sreekantan as SVP - Enterprise Sales
Quick Heal Technologies has appointed Mr. Rajiv Sreekantan as Senior Vice President - Enterprise Sales, effective August 11, 2026. This high-profile hire from IBM (26-year tenure) is strategically aligned with the company's pivot toward its 'Seqrite' enterprise segment, which now contributes 44% of gross revenue. Given the company's TTM net loss of ₹11 Cr and declining annual revenue (₹261 Cr in FY26 vs ₹292 Cr in FY24), this leadership change is critical for scaling B2B sales and government contracts.
Confidence: HIGH
What changedQuick Heal has replaced or added senior leadership for its most critical growth vertical, hiring a veteran from a global technology giant (IBM).
Why it mattersThe company is currently loss-making and facing headwinds in its traditional consumer business; the success of the Enterprise pivot is essential for returning to profitability and justifying its ₹807 Cr market cap.
Experience of Appointee: 30+ yearsTenure at IBM: 26 yearsEnterprise Revenue Contribution: 44%TTM Net Profit: ₹-11 CrTTM Revenue: ₹261 Cr
📅 Short termThe market may view this as a positive signal of the company's intent to professionalize and scale its B2B operations, potentially stabilizing the stock after a 46.7% 12-month decline.
📈 Long termIf the new leadership successfully leverages its experience with large-scale enterprise transformations, it could structurally shift Quick Heal from a retail-focused antivirus firm to a diversified B2B cybersecurity player.
⚠ Risk flags
- Execution risk in transitioning from a global MNC environment to a mid-cap Indian firm
- High cost of senior talent potentially impacting short-term margins
Key Highlights
Appointment of Rajiv Sreekantan as SVP - Enterprise Sales effective August 11, 2026
Mr. Sreekantan brings 30+ years of experience, including 26 years at IBM leading Enterprise Storage for Hybrid Cloud & AI
Enterprise segment (Seqrite) currently accounts for 44% of the company's gross revenue
Company reported a TTM net loss of ₹11 Cr, emphasizing the need for high-impact sales leadership
New appointee previously managed large-scale transformations for marquee clients like Reliance Jio
👀 What to Watch
Watch for growth in the Enterprise (Seqrite) revenue contribution and the conversion of 'big-ticket' government contracts in the next 2-4 quarters to validate the impact of this leadership change.
Resignation of SVP - Enterprise Sales, Mr. Samuel Sathyajith, by September 4, 2026
Quick Heal Technologies has announced the resignation of Mr. Samuel Sathyajith, Senior Vice President - Enterprise Sales, effective on or before September 4, 2026. This departure is significant as the company is currently pivoting its business model toward the Enterprise segment (Seqrite), which now contributes 44% of gross revenue. With a TTM revenue of ₹261 Cr and a net loss of ₹11 Cr, leadership stability in this growth-driving division is critical for the company's turnaround efforts. The stock has faced significant pressure, declining 47.3% over the last 12 months.
Confidence: HIGH
What changedThe head of the Enterprise Sales division, a key growth vertical for the company, has resigned to pursue other professional opportunities.
Why it mattersQuick Heal is strategically shifting from consumer to enterprise security; losing the leader of this 44% revenue-contributing segment during a loss-making period (₹-11 Cr TTM PAT) introduces execution risk.
Enterprise Revenue Contribution: 44%TTM Revenue: ₹261 CrTTM Net Profit: ₹-11 CrCessation Date: September 4, 202612-Month Price Return: -47.3%
📅 Short termThe market may react cautiously to the leadership churn in a vital growth segment, potentially adding to the recent downward stock price trend.
📈 Long termThe long-term impact depends on the company's ability to hire a replacement who can maintain the momentum of the Seqrite pivot and improve the current negative ROCE of -5.0%.
⚠ Risk flags
- Key management personnel turnover
- Execution risk in Enterprise segment pivot
- Ongoing net losses
Key Highlights
Mr. Samuel Sathyajith to step down as SVP - Enterprise Sales by September 4, 2026.
Enterprise segment (Seqrite) currently accounts for 44% of the company's gross revenue.
Company reported a TTM net loss of ₹11 Cr against a TTM revenue of ₹261 Cr.
EDR and XDR products constitute 90% of the enterprise revenue that the outgoing executive managed.
Stock price has seen a 12-month return of -47.3% as of the announcement date.
👀 What to Watch
Investors should monitor the company's announcement regarding a successor for the Enterprise Sales lead and track if the transition impacts the 13.60% expected growth rate in the Seqrite division.
₹5.28 Cr Net Loss in Q1 FY27; Revenue Declines 21% YoY to ₹44.99 Cr
Quick Heal Technologies reported a consolidated net loss of ₹5.28 Cr for Q1 FY27, compared to a loss of ₹5.51 Cr in the same period last year. Revenue from operations fell significantly by 21.4% YoY to ₹44.99 Cr, representing only 17% of TTM revenue. The bottom line was heavily supported by a one-time 'Other Income' of ₹14.10 Cr, which includes a ₹6.73 Cr service tax refund. Operationally, the company remains under pressure as employee benefit expenses of ₹43.20 Cr consumed nearly 96% of its operational revenue.
Confidence: HIGH
What changedQuick Heal reported its Q1 FY27 results showing a sharp revenue contraction and continued losses, alongside the formal start of the new CEO's tenure and a shift in registered office.
Why it mattersThe results highlight ongoing challenges in the consumer cybersecurity market and a high fixed-cost structure that makes the company vulnerable during low-revenue quarters.
Revenue (Q1 FY27): ₹44.99 CrYoY Revenue Growth: -21.4%Net Loss (Q1 FY27): ₹5.28 CrOne-time Tax Refund: ₹6.73 CrEmployee Cost as % of Revenue: 96.02%Revenue vs TTM Revenue: 17.2%
📅 Short termThe stock is likely to remain under pressure due to the double-digit revenue decline and operational losses, despite the one-time tax refund narrowing the net loss.
📈 Long termStructural recovery depends on the Enterprise segment (Seqrite) achieving enough scale to cover the high R&D and sales headcount costs, which are currently weighing on margins.
⚠ Risk flags
- High employee cost concentration
- Declining revenue trend in core operations
- Reliance on one-time other income to support PAT
Key Highlights
Revenue from operations declined 21.4% YoY to ₹44.99 Cr from ₹57.23 Cr in Q1 FY26.
Net loss narrowed slightly to ₹5.28 Cr from ₹5.51 Cr YoY, aided by non-operational income.
Other income included a ₹6.73 Cr refund of service tax pre-deposits and related interest.
Employee benefit expenses stood at ₹43.20 Cr, reflecting a high fixed-cost base relative to current revenue.
Mr. Richard Stiennon re-appointed as Independent Director for a second 5-year term starting September 2026.
👀 What to Watch
Investors should monitor the execution of the new CEO, Harish Kumar GS, specifically regarding the pivot to the Enterprise (Seqrite) segment to offset Consumer segment weakness. Watch for any reduction in the high employee-cost-to-revenue ratio in upcoming quarters.
Resignation of Chief Product Officer Dr. Lalit Mohan Sanagavarapu
Quick Heal Technologies has announced the resignation of its Chief Product Officer (CPO), Dr. Lalit Mohan Sanagavarapu, effective August 7, 2026. The resignation, cited for personal reasons, follows a discussion initiated on June 8, 2026. This leadership change occurs as the company is undergoing a critical pivot from its stagnant consumer business to the Enterprise segment (Seqrite), which now contributes 44% of gross revenue. Given the company's TTM loss of ₹11 crore and negative operating margins, the departure of a key product leader is a notable development for the execution of its R&D-heavy strategy.
Confidence: HIGH
What changedThe Chief Product Officer, a key senior management personnel responsible for product strategy and R&D, has exited the company.
Why it mattersThe CPO role is vital for Quick Heal's transition into the high-growth Enterprise cybersecurity market; leadership instability during a period of financial losses (₹11 cr TTM loss) could impact product innovation and market competitiveness.
Effective Date of Cessation: August 7, 2026Enterprise Revenue Contribution: 44%TTM Revenue: ₹261 crTTM PAT: ₹-11 crOperating Profit Margin (TTM): -11.1%
📅 Short termThe immediate impact may be neutral to slightly negative as the market processes the loss of a key executive during a turnaround phase.
📈 Long termThe long-term impact depends on the company's ability to attract a replacement who can maintain the momentum of the Seqrite enterprise brand and return the company to profitability.
⚠ Risk flags
- Key management personnel turnover
- Execution risk in product pivot
- Ongoing financial losses
Key Highlights
Dr. Lalit Mohan Sanagavarapu resigned as Chief Product Officer effective August 7, 2026
The resignation process was initiated two months prior, on June 8, 2026
Company is currently pivoting to the Enterprise segment which accounts for 44% of gross revenue
Quick Heal reported a TTM net loss of ₹11 crore and negative OPM of 11.1%
Enterprise revenue is heavily dependent on EDR and XDR products, contributing 90% of that segment's revenue
👀 What to Watch
Investors should monitor the company's announcement regarding a successor and check for any delays in the roadmap for new products like Sentinel Threat Intelligence (STI) and SMAP in upcoming quarterly updates.
Quick Heal Q1 FY27 Revenue Drops 21% to ₹45 Cr; Reports ₹5.3 Cr Net Loss
Quick Heal Technologies reported a weak Q1 FY27 with consolidated revenue declining 21.3% YoY to ₹45.0 cr, down from ₹57.2 cr. The company faced significant operating pressure with an EBITDA loss of ₹17.6 cr (margin of -39.1%) compared to a loss of ₹9.7 cr in the previous year. Net loss narrowed slightly to ₹5.3 cr from ₹5.5 cr YoY, primarily supported by a sharp increase in 'Other Income' to ₹14.1 cr. Despite consumer segment headwinds, the company secured a notable multi-year order for 1.5 lakh devices from the Defence sector.
Confidence: HIGH
What changedQuick Heal reported a significant year-on-year revenue contraction and widened operating losses for Q1 FY27, while simultaneously announcing a major government order win and the re-appointment of a key independent director.
Why it mattersThe results highlight the ongoing struggle in the company's core consumer business, making the pivot to Enterprise and Government segments (B2B/B2G) critical for financial recovery and long-term sustainability.
Q1 FY27 Revenue: ₹45.0 crYoY Revenue Growth: -21.3%Q1 FY27 PAT: ₹-5.3 crEBITDA Margin: -39.1%Other Income: ₹14.1 crDefence Order Size: 1.5 lakh devices
📅 Short termThe stock is likely to face negative sentiment in the short term due to the double-digit revenue decline and continued operating losses.
📈 Long termThe long-term outlook depends on the successful scaling of the Seqrite enterprise arm and high-margin government contracts to replace the shrinking consumer software base.
⚠ Risk flags
- Continued revenue contraction in the consumer segment
- Widening operating losses
- High reliance on non-operating income to support PAT
- Collection challenges from retail partners
Key Highlights
Revenue for Q1 FY27 fell 21.3% YoY to ₹45.0 cr due to continued headwinds in the consumer cybersecurity segment.
EBITDA loss widened to ₹17.6 cr from ₹9.7 cr in Q1 FY26, reflecting poor operating leverage.
Other Income surged to ₹14.1 cr from ₹5.8 cr YoY, acting as a significant buffer for the bottom line.
Secured a major multi-year contract to protect 1.5 lakh devices in the Defence sector.
Research and Development expenses were reduced to ₹28.1 cr from ₹31.3 cr in the year-ago period.
👀 What to Watch
Investors should monitor the execution timeline of the 1.5 lakh device Defence order and the pace of the 'Seqrite' enterprise segment's growth to offset consumer segment declines. Watch for stabilization in operating margins and partner credit control in upcoming quarters.
Quick Heal re-appoints cybersecurity expert Richard Stiennon for a 5-year second term
Quick Heal Technologies has proposed the re-appointment of Mr. Richard Stiennon as a Non-Executive Independent Director for a second five-year term, effective September 27, 2026. Stiennon is a globally recognized cybersecurity analyst with over 30 years of experience, having advised industry leaders like Symantec, McAfee, and Microsoft. This retention of high-caliber global expertise is significant as the company pivots toward its Enterprise segment (Seqrite), which now accounts for 44% of gross revenue. The move comes as the company seeks to reverse a TTM net loss of ₹11 Cr through international expansion and product diversification.
Confidence: HIGH
What changedThe Board has recommended the extension of Richard Stiennon's tenure as an Independent Director for an additional five years, subject to shareholder approval.
Why it mattersRetaining a director with deep global cybersecurity expertise is crucial for Quick Heal's strategic shift toward Enterprise solutions and its expansion into Southeast Asia and Middle Eastern markets, especially given recent financial headwinds.
Term Duration: 5 yearsEffective Date: September 27, 2026Industry Experience: 30+ yearsEnterprise Revenue Contribution: 44%TTM Revenue: ₹261 Cr
📅 Short termThe announcement provides stability and continuity at the board level, which is likely to be viewed neutrally to slightly positively by the market in the coming weeks.
📈 Long termStiennon's continued involvement is structurally significant for the company's R&D and international strategy as it attempts to transition from a consumer-focused player to a global enterprise security provider.
Key Highlights
Re-appointment for a second term of 5 consecutive years from September 27, 2026, to September 26, 2031.
Richard Stiennon brings over 30 years of experience, including senior roles at Gartner, PwC, and Fortinet.
The Enterprise segment (Seqrite) supported by such expertise now contributes 44% of gross revenue.
Quick Heal is targeting a 13.60% expected growth rate by pivoting from stagnant consumer segments.
The company maintains a premium positioning with 15% to 20% price premiums over competitors like McAfee.
👀 What to Watch
Investors should monitor the upcoming Annual General Meeting (AGM) for shareholder approval of this re-appointment and look for updates on the Enterprise segment's growth in subsequent quarterly results.
Quick Heal Q1 FY27: Revenue Drops 21% to ₹45 Cr; Net Loss Narrows to ₹5.3 Cr on Other Income
Quick Heal reported a challenging Q1 FY27 with revenue declining 21.3% YoY to ₹45.0 Cr, down from ₹57.2 Cr in Q1 FY26. The company recorded an EBITDA loss of ₹17.6 Cr, significantly wider than the ₹9.7 Cr loss in the previous year, as consumer segment headwinds persisted. However, the net loss narrowed slightly to ₹5.3 Cr (from ₹5.5 Cr) primarily due to a sharp increase in other income to ₹14.1 Cr. On the strategic front, the company secured a multi-year order for 1.5 lakh devices in the Defence sector and appointed Harish Kumar G S as the new CEO.
Confidence: HIGH
What changedThe company has transitioned to a new CEO and shifted its registered office, while reporting a significant operational downturn in its first quarter of FY27.
Why it mattersThe results highlight a deepening struggle in the core consumer business, making the pivot to Enterprise and Government (B2G) segments critical for the company's survival and return to profitability.
Q1 FY27 Revenue: ₹45.0 CrRevenue Growth (YoY): -21.3%EBITDA Loss: ₹17.6 CrOther Income: ₹14.1 CrDefence Order Size: 1.5 lakh devicesQ1 Revenue vs TTM Revenue: 17.2%
📅 Short termThe stock may face pressure due to the sharp decline in revenue and widening operating losses, despite the bottom-line being cushioned by non-operating income.
📈 Long termThe long-term outlook depends on the new CEO's ability to scale the Seqrite Enterprise business and successfully execute large-scale government contracts like the recent Defence order.
⚠ Risk flags
- Continued operating losses at the EBITDA level
- Declining revenue in the core consumer segment
- High reliance on non-operating 'Other Income' to support PAT
- Execution risk associated with large-scale government contracts
Key Highlights
Revenue declined 21.3% YoY to ₹45.0 Cr, reflecting continued pressure in the consumer cybersecurity segment.
EBITDA loss widened to ₹17.6 Cr from ₹9.7 Cr in Q1 FY26, with EBITDA margins dropping to -39.1%.
Other income surged to ₹14.1 Cr from ₹5.8 Cr YoY, which was the primary driver in narrowing the net loss to ₹5.3 Cr.
Secured a significant multi-year order to secure 1.5 lakh devices for the Defence sector.
Appointed Harish Kumar G S as CEO to lead the pivot toward AI-driven enterprise cybersecurity.
👀 What to Watch
Investors should monitor the pace of the Enterprise (Seqrite) segment's growth to see if it can offset the double-digit decline in the Consumer business. Key metrics to watch include the execution timeline of the 1.5 lakh device Defence order and the sustainability of 'Other Income' which currently masks operational losses.
Quick Heal Appoints Cybersecurity Veteran Harish Kumar GS as CEO
Quick Heal Technologies Limited has appointed Mr. Harish Kumar GS as its Chief Executive Officer and Key Managerial Personnel, effective June 18, 2026. Mr. Kumar brings over 30 years of leadership experience in cybersecurity, enterprise software, and technology infrastructure. He previously served as the Head of Sales – India & SAARC at Check Point Software Technologies, a major global cybersecurity firm. This strategic appointment is aimed at driving business transformation and expanding the company's market presence in the mid-market and large enterprise segments.
Key Highlights
Appointment of Mr. Harish Kumar GS as CEO and Key Managerial Personnel effective June 18, 2026.
Brings over 30 years of experience across cybersecurity, networking, and digital services.
Previously served as Head of Sales – India & SAARC at Check Point Software Technologies.
The appointment was approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee.
👀 What to Watch
Investors should view this as a positive move to strengthen leadership with a veteran from a global cybersecurity leader; monitor for potential shifts in enterprise sales strategy and market expansion.
Quick Heal Appoints Harish Kumar GS as CEO and Key Managerial Personnel
Quick Heal Technologies Limited has appointed Mr. Harish Kumar GS as its Chief Executive Officer and Key Managerial Personnel, effective June 18, 2026. Mr. Kumar brings over 30 years of experience in cybersecurity and technology infrastructure to the role. He previously served as the Head of Sales – India & SAARC at Check Point Software Technologies, a major global competitor. This strategic leadership change is aimed at driving business transformation and expanding market presence in the competitive cybersecurity sector.
Key Highlights
Appointment of Mr. Harish Kumar GS as CEO and KMP effective from June 18, 2026.
Mr. Kumar has over 3 decades of experience across cybersecurity, enterprise software, and technology infrastructure.
Previously held a senior leadership role as Head of Sales – India & SAARC at Check Point Software Technologies.
The board meeting approving the appointment concluded at 1:10 PM on June 18, 2026.
The appointee has a proven track record of leading large-scale business transformations and high-performing teams.
👀 What to Watch
Investors should view this as a positive development as the company has hired a veteran from a global cybersecurity leader to drive growth. Monitor upcoming quarterly results for signs of strategic shifts in the enterprise and mid-market segments.
Quick Heal FY26 Revenue Drops 6.6% to ₹261 Cr; Swings to Annual Net Loss of ₹10.9 Cr
Quick Heal Technologies reported a weak financial performance for FY26, with consolidated revenue from operations declining 6.6% YoY to ₹261.02 Cr. The company swung to a consolidated net loss of ₹10.93 Cr for the full year, compared to a profit of ₹5.04 Cr in FY25. The fourth quarter was particularly poor, with revenue falling 25.2% YoY to ₹48.73 Cr and net losses widening significantly to ₹19.94 Cr. Additionally, the company announced the appointment of Rohit Kachroo as Senior Director for IT & Digital Transformation to bolster its management team.
Key Highlights
Consolidated FY26 revenue declined to ₹261.02 Cr from ₹279.53 Cr in the previous year.
Reported a consolidated net loss of ₹10.93 Cr for FY26 versus a profit of ₹5.04 Cr in FY25.
Q4 FY26 revenue saw a sharp decline of 25.2% YoY, falling to ₹48.73 Cr.
Total expenses for FY26 rose to ₹304.49 Cr, with 'Other Expenses' increasing to ₹103.21 Cr.
Cash and cash equivalents decreased to ₹13.14 Cr as of March 31, 2026, down from ₹20.84 Cr YoY.
👀 What to Watch
Investors should exercise caution as the company has moved from profitability to a loss-making position amid declining revenues. Monitor management's commentary regarding the turnaround strategy and the impact of new leadership on digital transformation.
Quick Heal CTO Ashish Pradhan Announces Early Retirement Effective April 30, 2026
Quick Heal Technologies Limited has announced that its Chief Technology Officer, Mr. Ashish Pradhan, retired from his position effective April 30, 2026. This move is categorized as an early retirement, following a previous extension of service granted beyond his original retirement date of August 06, 2024. As the CTO of a cybersecurity firm, his departure marks a significant transition in the company's technical leadership. The company has not yet announced a successor for the role.
Key Highlights
Mr. Ashish Pradhan retired as Chief Technology Officer effective April 30, 2026.
The executive opted for early retirement after serving an extension period.
His original retirement date was previously set for August 06, 2024.
The transition was filed under Regulation 30 of SEBI (LODR) Regulations, 2015.
👀 What to Watch
Investors should watch for the appointment of a new CTO to ensure continuity in the company's product development and cybersecurity roadmap. No immediate portfolio changes are recommended as the departure appears planned and amicable.
Quick Heal Strengthens Leadership with Four Senior Management Appointments
Quick Heal Technologies has announced a significant expansion of its senior leadership team with four key appointments and promotions effective January 29, 2026. The company has hired industry veterans including Ms. Savita Nehra (20+ years exp) as VP People and Culture and Mr. Amartya Mukherjee (25+ years exp) as VP and Head of Delivery. Additionally, Ms. Netra Deshpande (25+ years exp) has been promoted to Head of Engineering, and Mr. Nitin Bhogan (15+ years exp) joins as Director of Cyber Awareness. These appointments bring a combined experience of over 85 years from top-tier firms like Accenture, IBM, and Symantec to the company.
Key Highlights
Ms. Savita Nehra joins as VP People and Culture with over 20 years of HR experience from Wipro and Capgemini.
Mr. Amartya Mukherjee appointed as VP and Head of Delivery, bringing 25+ years of experience from Accenture and IBM.
Ms. Netra Deshpande promoted to Head of Engineering with 25+ years in cybersecurity product development including Symantec.
Mr. Nitin Bhogan appointed as Director Cyber Awareness with 15+ years of experience in risk consulting and Mahindra SSG.
👀 What to Watch
Investors should view this as a positive move to bolster execution and product delivery capabilities. Monitor if this leadership infusion leads to improved product innovation and faster market expansion in the cybersecurity segment.
Quick Heal Q3 PAT Surges to ₹6.61 Cr; YoY Profitability Improves Significantly
Quick Heal Technologies reported a significant turnaround in profitability for Q3 FY26, with net profit rising to ₹6.61 crore from just ₹0.11 crore in the same period last year. While revenue from operations saw a modest YoY increase to ₹71.54 crore, it declined sequentially from ₹83.52 crore in Q2. The company also announced a major leadership expansion with four senior management appointments and the re-classification of a promoter entity to the public category.
Key Highlights
Net Profit (PAT) grew to ₹6.61 Cr in Q3 FY26, a massive jump from ₹0.11 Cr in Q3 FY25.
Revenue from operations stood at ₹71.54 Cr, up 1.3% YoY but down 14.3% QoQ.
9-month PAT for FY26 reached ₹9.01 Cr compared to ₹8.29 Cr in the previous year.
Appointed four senior leaders including Savita Nehra (VP People and Culture) and Amartya Mukherjee (VP and Head of Delivery).
Board approved the re-classification of Gagan Bharari Enterprises LLP from 'Promoter' to 'Public' category.
👀 What to Watch
The sharp YoY recovery in net profit is encouraging, though the sequential decline in revenue suggests seasonal or cyclical volatility. Investors should watch for the impact of the new leadership team on driving consistent top-line growth in the upcoming quarters.
Quick Heal Q3 PAT Surges to ₹6.61 Cr; Strengthens Leadership with Key Senior Appointments
Quick Heal Technologies reported a significant turnaround in profitability for Q3 FY26, with Profit After Tax (PAT) rising to ₹6.61 Cr from a marginal ₹0.11 Cr in the same period last year. Revenue from operations saw a modest year-on-year growth of 1.3% to reach ₹71.54 Cr, while the company successfully reduced total expenses to ₹74.74 Cr. A major highlight is the aggressive strengthening of the leadership team, with new senior hires from global firms like Accenture, Wipro, and Symantec. Additionally, the board approved a promoter group entity's request to re-classify as a public shareholder.
Key Highlights
Consolidated PAT jumped to ₹6.61 Cr in Q3 FY26 compared to ₹0.11 Cr in Q3 FY25.
Revenue from operations stood at ₹71.54 Cr, up from ₹70.61 Cr in the previous year's corresponding quarter.
Total expenses decreased to ₹74.74 Cr from ₹77.83 Cr YoY, driven by better cost management.
Appointed four senior leaders including Savita Nehra (VP People) and Amartya Mukherjee (VP Delivery) to drive growth.
Promoter group entity Gagan Bharari Enterprises LLP applied for re-classification to the Public category.
👀 What to Watch
The significant improvement in bottom-line performance and the induction of high-caliber leadership from global tech giants are positive indicators. Investors should watch for accelerated revenue growth as the new management team begins to execute its strategy.
